SCHEMBL8707174

SCHEMBL8707174

CCN(CC)CCOc1ccc(CC(O)(c2ccccc2)c2ccccc2OC)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EBP Q15125 6/20 0.56
▸ SIGMAR1 Q99720 5/20 0.56
▸ CYP2D6 P10635 2/20 0.52
▸ HTT P42858 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ LTA4H P09960 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ ESR1 P03372 6/20 0.45
▸ ESR2 Q92731 4/20 0.45
▸ DHCR7 Q9UBM7 2/20 0.45
▸ DRD3 P35462 3/20 0.44
▸ KCNH2 Q12809 2/20 0.44
▸ CHRM2 P08172 2/20 0.44
▸ ADRA2A P08913 2/20 0.44
▸ ADORA3 P0DMS8 2/20 0.44
▸ CHRM1 P11229 2/20 0.44
▸ PTGS1 P23219 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10879788 0.88 KMT2A (0.53) EBPSIGMAR1CYP2D6HTTCYP1A2
SCHEMBL330094 0.86 SIGMAR1 (0.67) EBPSIGMAR1CYP2D6HTTCYP1A2
SCHEMBL16910242 0.84 SIGMAR1 (0.69) EBPSIGMAR1CYP2D6HTTCYP1A2
SCHEMBL6769894 0.82 CYP2D6 (0.48) EBPSIGMAR1CYP2D6HTTCYP1A2
SCHEMBL4314565 0.82 EBP (0.53) EBPSIGMAR1CYP2D6HTTCYP1A2
SCHEMBL10880305 0.82 MEN1 (0.52) EBPSIGMAR1CYP2D6HTTCYP1A2
SCHEMBL6009065 0.81 CYP2D6 (0.51) EBPSIGMAR1CYP2D6HTTCYP1A2
SCHEMBL7753432 0.78 SIGMAR1 (0.79) EBPSIGMAR1CYP2D6HTTCYP1A2
SCHEMBL2896442 0.78 CYP2D6 (0.54) EBPSIGMAR1CYP2D6HTTCYP1A2
SCHEMBL3294808 0.78 CYP2D6 (0.54) EBPSIGMAR1CYP2D6HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998046588-A2 COMPOUNDS AND THERAPIES FOR THE PREVENTION OF VASCULAR AND NON-VASCULAR PATHOLOGIES NEORX CORPORATION (US) 1998-10-22 — — WO disclosed
EP-0833624-A2 PREVENTION AND TREATMENT OF CARDIOVASCULAR PATHOLOGIES WITH TAMOXIFEN ANALOGUES NEORX CORPORATION (US) 1998-04-08 — — EP disclosed
WO-1996040098-A2 PREVENTION AND TREATMENT OF CARDIOVASCULAR PATHOLOGIES WITH TAMOXIFEN ANALOGUES NEORX CORPORATION (US) 1996-12-19 — — WO disclosed
Send feedback